Primary HIV-1 infection in Zurich: 2002-2004;Die akute HIV-1-infektion in Zürich: 2002-2004

Praxis

Volumn 94, Issue 32, 2005, Pages 1199-1205

  Aceto, L ^a   Karrer, U ^a   Grube, Ch ^a   Oberholzer, R ^a   Hasse, B ^a   Presterl, E ^a   Boni J ^b   Kuster, H ^a   Trkola, A ^a   Weber, R ^a   Gunthard H F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Acute HIV infection; Acute retroviral syndrome; HIV drug resistance; Primary HIV infection; Sexually transmitted diseases

Indexed keywords

EID: 80051664545     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.94.32.1199     Document Type: Article

References (25)

1. Battegay M, Hirschel B. [Primary HIV infection]. Ther Umsch 2004; 61:609-12.
2. Kahn JO,Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9.
3. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-64. (Pubitemid 126449269)
4. Cates W, Jr., Chesney MA, Cohen MS. Primary HIV infection - a public health opportunity. Am J Public Health 1997; 87:1928-30. (Pubitemid 28055907)
5. Pilcher CD, Tien HC, Eron JJ, Jr., et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189:1785-92. (Pubitemid 38657214)
6. Schupbach J. [SHCS and the laboratory diagnosis of HIV infection - from the development of the HIV Western blot to virus quantification and clinically relevant individual virus characterization]. Ther Umsch 2004; 61:603-7.
7. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med 2001; 134:25-9.
8. Rusert P, Kuster H, Joos B, et al. Virus isolates during acute and chronic HIV-1 infection show distinct pattern of sensitivity to entry inhibitors. The Journal of Virology 2005; in press.
9. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Jama 1998; 280:42-8. (Pubitemid 28414995)
10. Binley JM, Arshad H, Fouts TR, Moore JP. An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1997; 13:1007-15. (Pubitemid 27330087)
11. Bundesamt für Gesundheit AEuI. Aids-Statistik. BAG-Bulletin 2002:70-71.
12. Bundesamt für Gesundheit AEuI. Aids-Statistik. BAG-Bulletin 2003:68-69.
13. Zwahlen M, Gebhardt M, Rickenbach M, Egger M. Die Schweizerische HIV-Kohortenstudie - Ressource für Epidemiologie und Prävention. Therapeutische Umschau 2004; 61:593-598. (Pubitemid 39420808)
14. Flepp M, Ledergerber B. Die Schweizerische HIV-Kohortenstudie - ein Netzwerk gespannt zwischen individueller Patienten-Betreuung und internationaler Forschungs-Zusammenarbeit. Therapeutische Umschau 2004; 61:635-638. (Pubitemid 39420816)
15. Desquilbet L, Deveau C, Goujard C, Hubert JB, Derouineau J, Meyer L. Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort. Aids 2002; 16:2329-33. (Pubitemid 35449020)
16. Watson A, McClure J, Ranchalis J, et al. Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. AIDS Res Hum Retroviruses 1997; 13:1375-81. (Pubitemid 27460834)
17. Strain MC, Little SJ, Daar ES, et al. Effect of treatment during primary infection on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis 2005; 191:1410-18. (Pubitemid 40563351)
18. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.
19. Smith DE,Walker BD, Cooper DA, Rosenberg ES, Kaldor JM. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? Aids 2004; 18:709-18. (Pubitemid 38534999)
20. Kaufmann DE, Lichterfeld M, Altfeld M, et al. Limited Durability of Viral Control following Treated Acute HIV Infection. Plos Med 2004; 1:e36.
21. Yerly S, Vora S, Rizzardi P, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. Aids 2001; 15:2287-92. (Pubitemid 34059836)
22. Boni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr 1999; 22:174-9.
23. Perrin L, Kaiser L, Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 2003; 3:22-7. (Pubitemid 36041785)
24. Yerly S, Jost S, Telenti A, et al. Infrequent transmission of HIV-1 drug-resistant variants. Antivir Ther 2004; 9:375-84. (Pubitemid 38878753)
25. Hasse B, Hummel Y, Boni J, Schupbach J, Flepp M, Gunthard HF. [25-year-old therapy naive patient with 3 class resistant HIV infection]. Schweiz Rundsch Med Prax 2003; 92:601-5.